Pharmacogenomics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
Pharmacogenomics is the individualisation of drug therapies to patients using their genetic information. Sequencing a patients genome allows genetic variations to be identified, such as single nucleotide polymorphism. Tailoring treatment to an individual increases the effectiveness and reduces the chance of adverse side effects | Pharmacogenomics is the individualisation of drug therapies to patients using their [[genetic information|genetic information]]. Sequencing a patients [[Genome|genome]] allows [[genetic variation|genetic variations]] to be identified, such as [[SNP|single nucleotide polymorphism]]. Tailoring treatment to an individual increases the effectiveness and reduces the chance of adverse side effects <ref>American Medical Association, 2014. Pharmacogenomics [online] Available at: &lt;http://www.ama-assn.org/ama/pub/physician-resources/medical-science/genetics-molecular-medicine/current-topics/pharmacogenomics.page&gt; Accessed:[16/10/14]</ref>. | ||
=== '''Reference ''' === | === '''Reference ''' === | ||
'''<references />''' | '''<references />''' | ||
Revision as of 01:16, 17 October 2014
Pharmacogenomics is the individualisation of drug therapies to patients using their genetic information. Sequencing a patients genome allows genetic variations to be identified, such as single nucleotide polymorphism. Tailoring treatment to an individual increases the effectiveness and reduces the chance of adverse side effects [1].
Reference
- ↑ American Medical Association, 2014. Pharmacogenomics [online] Available at: <http://www.ama-assn.org/ama/pub/physician-resources/medical-science/genetics-molecular-medicine/current-topics/pharmacogenomics.page> Accessed:[16/10/14]